Comment on Han L et al.: Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 8353-8354

  Li, Chenggang ^a   Zhao, Zhiming ^a   Liu, Rong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CIRCULATING TUMOR CELL; DISEASE MARKER; EDITORIAL; HAZARD RATIO; HUMAN; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PANCREAS CANCER; PROGRESSION FREE SURVIVAL; BLOOD; MORTALITY; PANCREAS TUMOR; TUMOR EMBOLISM;

HUMANS; NEOPLASTIC CELLS, CIRCULATING; PANCREATIC NEOPLASMS;

EID: 84919664769     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2507-7     Document Type: Editorial

References (10)

1. Han L, Chen W, Zhao Q. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Tumor Biol. 2014;35(1):2473–80.
2. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508–16.
3. Bidard FC, Huguet F, Louvet C, Mineur L, Bouche O, et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol. 2013;24:2057–61.
4. de Albuquerque A, Kubisch I, Breier G, Stamminger G, Fersis N, et al. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. Oncology. 2012;82:3–10.
5. Hu L, Zhou JH, Yu ZQ, Yi YX, Ding H, et al. Clinical significance of h-TERT and c-Met expression in the peripheral blood circulation of pancreatic cancer patients. Chin J Clin Oncol. 2013;40:208–11.
6. Soeth E, Grigoleit U, Moellmann B, Roder C, Schniewind B, et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol. 2005;131:669–76.
7. Hirooka S, Yanagimoto H, Satoi S, Yamamoto T, Toyokawa H, et al. The role of circulating dendritic cells in patients with unresectable pancreatic cancer. Anticancer Res. 2011;31:3827–34.
8. Kurihara T, Itoi T, Sofuni A, Itokawa F, Tsuchiya T, et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreatol Surg. 2008;15:189–95.
9. Sergeant G, Roskams T, van Pelt J, Houtmeyers F, Aerts R, et al. Perioperative cancer cell dissemination detected with a real-time RTPCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer. 2011;11:47.
10. Uchikura K, Takao S, Nakajo A, Miyazono F, Nakashima S, et al. Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol. 2002;9:364–70.